NASDAQ:DFFN
Delisted
Diffusion Pharmaceuticals Inc Stock News
$5.87
+0 (+0%)
At Close: Nov 28, 2023
Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock
04:13pm, Wednesday, 17'th Feb 2021
CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel
DFFN Stock Price Increases Over 20% Pre-Market: Why It Happened
09:02am, Tuesday, 16'th Feb 2021
The stock price of Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) is trading at over 20% pre-market. This is why it happened.
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
07:35am, Tuesday, 16'th Feb 2021
No Dose Limiting Toxicities or Serious Adverse Events Observed in Dosing Regimen Previously Untested in Clinical Trial Setting No Dose Limiting Toxicities or Serious Adverse Events Observed in Dosing
Diffusion Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $30 Million
10:02pm, Thursday, 11'th Feb 2021
CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative clinical stage biopharmaceutical company de
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
05:54pm, Thursday, 11'th Feb 2021
CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative clinical stage biopharmaceutical company de
Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference
07:30am, Monday, 11'th Jan 2021
CHARLOTTESVILLE, Va., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced that the Company is participating in the
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
04:02pm, Thursday, 12'th Nov 2020
Initiated and Advanced C linical Trial Evaluating Lead Product Candidate in COVID-19 Patients
Акции «Яндекса» на рекордном уровне: аналитики одобряют сделку с «Тинькофф Банк»
10:55am, Thursday, 24'th Sep 2020
Инвесторы вкладываются в акции «Яндекса» после сделки, которая сделает технологический гигант ведущей росс�
Ligand Acquisitions, And Other News: The Good, Bad And Ugly Of Biopharma
02:16pm, Monday, 14'th Sep 2020
Ligand inks deal to acquire Taurus and xCella Biosciences. Zogenix reports positive data from pivotal Phase 3 clinical trial.
Insider Buys TriState Capital's Shares
12:00am, Wednesday, 19'th Aug 2020
TriState Capital Holdings Inc (NASDAQ:TSC) was trading 1.3% higher from the previous closing price. A Form 4 filing filed with the SEC on Wednesday, August 19 showed that CEO TSC...
Relief Therapeutics Discovers A Promising COVID-19 Killer (OTCMKTS:RLFTF)
01:25pm, Tuesday, 11'th Aug 2020
Relief Therapeutics is in advanced clinical trials with their drug RLF-100 which aims to halt COVID-19 and reverse its devastating effects; Just-released Compassionate Use results showed stunning resu
CEL-SCI Corporation Reports Third Quarter Fiscal 2020 Financial Results
12:00am, Tuesday, 11'th Aug 2020
CEL-SCI Corporation reports third quarter fiscal 2020 financial results.
Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
12:00pm, Monday, 10'th Aug 2020
Continues global clinical development of TSC for the treatment of COVID-19CHARLOTTESVILLE, Va., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “t
GW Pharmaceuticals PLC (GWPH) Q2 2020 Earnings Call Transcript | The Motley Fool
09:31pm, Friday, 07'th Aug 2020
GWPH earnings call for the period ending June 30, 2020.
GW Pharma shares slide 12% after company swings to loss during pandemic
03:24pm, Friday, 07'th Aug 2020
Shares of GW Pharmaceuticals PLC undefined slumped 12% Friday, after the company swung to a loss in the second quarter, hurt by the effect of the coronavirus...
